Cargando…
Impact of baseline culture conditions of cancer organoids when determining therapeutic response and tumor heterogeneity
Representative models are needed to screen new therapies for patients with cancer. Cancer organoids are a leap forward as a culture model that faithfully represents the disease. Mouse-derived cancer organoids (MDCOs) are becoming increasingly popular, however there has yet to be a standardized metho...
Autores principales: | DeStefanis, Rebecca A., Kratz, Jeremy D., Olson, Autumn M., Sunil, Aishwarya, DeZeeuw, Alyssa K., Gillette, Amani A., Sha, Gioia C., Johnson, Katherine A., Pasch, Cheri A., Clipson, Linda, Skala, Melissa C., Deming, Dustin A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956720/ https://www.ncbi.nlm.nih.gov/pubmed/35338174 http://dx.doi.org/10.1038/s41598-022-08937-z |
Ejemplares similares
-
Autofluorescence Imaging of Treatment Response in Neuroendocrine Tumor Organoids
por: Gillette, Amani A., et al.
Publicado: (2021) -
Inhibition of B-cell lymphoma 2 family proteins alters optical redox ratio, mitochondrial polarization, and cell energetics independent of cell state
por: Gillette, Amani A., et al.
Publicado: (2022) -
Colon Cancer Tumorigenesis Initiated by the H1047R Mutant PI3K
por: Yueh, Alexander E., et al.
Publicado: (2016) -
Patient-derived cancer organoid tracking with wide-field one-photon redox imaging to assess treatment response
por: Gil, Daniel A., et al.
Publicado: (2021) -
Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment
por: Sharick, Joe T., et al.
Publicado: (2020)